Who
Andrew Gottesdiener
Director
Company insider
Files Form 4 as: Director, Korsana Biosciences; Director, Apogee Therapeutics.
In numbers
- Trades disclosed
- 5
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 13 Jul 2023
- Last trade
- 9 Sep 2026
- Last filed
- 10 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Sep 2026filed 10 Sep 2026 | Korsana Biosciencesoption or derivative | SEC FORM 4 Code A | —48,445 at $0.00 | filing |
| 9 Sep 2026filed 10 Sep 2026 | KRSA Korsana Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —48,445 at $0.00 | filing |
| 17 Jun 2025filed 20 Jun 2025 | Apogee Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,461 at $0.00 | filing |
| 5 Jun 2024filed 7 Jun 2024 | Apogee Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,370 at $0.00 | filing |
| 13 Jul 2023filed 17 Jul 2023 | Apogee Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —47,758 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.